MedTrace Logo

Combined Laser-surgical Technology of RRD Treatment

NCT04403750 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-05-29

No results posted yet for this study

Summary

Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment

Conditions

  • Rhegmatogenous Retinal Detachment

Interventions

PROCEDURE

Combined laser-surgical technology of RRD treatment

1. Nd-YAG laser excision of the vitreoretinal traction zone 2. Pneumatic retinopexy (10% C3F8) 3. barrier laser photocoagulation around retinal break after retinal attachment (2-3 days after pneumatic retinopexy)

Sponsors & Collaborators

  • The S.N. Fyodorov Eye Microsurgery State Institution

    lead OTHER_GOV

Principal Investigators

  • Leonid Kryl, PhD, MD · S.N. Fyodorov Eye Microsurgery State Institution.

  • Mariiam Taevere, MD · S.N. Fyodorov Eye Microsurgery State Institution.

  • Alexander Doga, Professor · S.N. Fyodorov Eye Microsurgery State Institution.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2020-06-25
Completion
2021-06-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403750 on ClinicalTrials.gov